Can a liver ultrasound be normal in a patient with polycythemia vera (PV)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can a Liver Ultrasound Be Normal in Polycythemia Vera?

Yes, a liver ultrasound can be completely normal in polycythemia vera, particularly in early disease or when vascular complications have not yet developed. 1

Understanding the Relationship Between PV and Liver Imaging

Polycythemia vera does not inherently cause structural liver abnormalities that would be visible on ultrasound. The liver parenchyma itself is typically normal unless complications develop. 1 The key ultrasound findings in PV are related to vascular complications, not primary liver disease.

When Ultrasound Findings Are Normal

A normal liver ultrasound in PV occurs when:

  • No thrombotic complications have developed - The hepatic veins, portal vein, and inferior vena cava remain patent without thrombosis 1
  • Portal hypertension has not yet occurred - No splenomegaly, no portosystemic collaterals, and normal portal vein diameter 1
  • Early disease stage - Before the hyperviscosity and thrombotic tendency have caused vascular events 2, 3

Critical Vascular Complications to Assess

When performing ultrasound in PV patients, the focus should be on detecting:

Budd-Chiari Syndrome

  • PV accounts for approximately 49% of all Budd-Chiari syndrome cases, making this the most important complication to exclude 1, 4
  • Doppler ultrasound should specifically assess hepatic vein patency, as it has diagnostic sensitivity >75% for Budd-Chiari syndrome 1, 4
  • Non-visualization of hepatic veins is the hallmark finding, though ultrasound can have false positive/indeterminate results in approximately 50% of cases 4, 5
  • Large intrahepatic or subcapsular collateral vessels are present in >80% of Budd-Chiari cases 1, 4

Portal Hypertension Features

  • Portosystemic collaterals on ultrasound are 100% specific for clinically significant portal hypertension and should be actively searched for 6, 1
  • Splenomegaly should be measured and documented, as it contributes to risk stratification 6, 1
  • Portal vein thrombosis with cavernous transformation can occur in PV patients with non-cirrhotic portal hypertension 7

Clinical Context Matters

The absence of ultrasound abnormalities does not exclude PV - the diagnosis is based on hematologic criteria (elevated red cell mass, JAK2V617F mutation in >95% of cases, bone marrow findings), not imaging 3, 8

Conversely, unusual thrombosis patterns in patients under 55 years without chronic liver disease should prompt evaluation for PV, even when other findings are subtle 1

Important Clinical Pitfalls

  • Do not assume liver disease is present based solely on a PV diagnosis - the liver ultrasound may remain normal throughout the disease course if vascular complications do not develop 1
  • Splenomegaly in PV has multiple causes - it can result from extramedullary hematopoiesis (part of the myeloproliferative process itself) or from portal hypertension secondary to thrombotic complications 2, 7
  • Four out of five patients in one case series had moderate-to-severe esophageal varices despite relatively preserved liver function (Child A-B), indicating that portal hypertension can develop without cirrhosis in PV 7
  • If thrombotic complications are suspected but ultrasound is equivocal, MRI or direct venography should be pursued rather than assuming the ultrasound excludes pathology 4

Surveillance Recommendations

In PV patients with normal baseline ultrasound:

  • Esophagogastroduodenoscopy should be performed early and regularly if any signs of portal hypertension develop, as primary prevention of variceal hemorrhage is critical 7
  • Serial ultrasound monitoring may be warranted in patients with additional thrombotic risk factors (age >60 years, prior thrombosis, poorly controlled blood counts) 3, 7
  • Doppler assessment of hepatic veins should be included in any abdominal ultrasound performed on PV patients to screen for early Budd-Chiari syndrome 1, 4

References

Guideline

Liver Ultrasound Findings in Polycythemia Vera

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Polycythemia vera.

Disease-a-month : DM, 1992

Research

Polycythaemia vera.

Nature reviews. Disease primers, 2025

Guideline

Diagnostic Approach to Budd-Chiari Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

CT Angiogram Findings in Budd-Chiari Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.